Focus Partners Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Focus Partners Wealth's LLY Position: Q3 2026 in Review
Focus Partners Wealth increased its Eli Lilly (LLY) stake by 2.3% in Q3 2026, buying an estimated $6.92M and bringing the position to 265,911 shares worth $308M. The position accounts for 0.32% of the portfolio, ranked #64.
Focus Partners Wealth first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $312M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Focus Partners Wealth held 265,911 shares of Eli Lilly worth $308M as of Q3 2026.
- Focus Partners Wealth bought 5,866 Eli Lilly shares in Q3 2026, an estimated $6.92M.
- Eli Lilly made up 0.32% of Focus Partners Wealth's portfolio in Q3 2026, its #64 holding.
- Focus Partners Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- Focus Partners Wealth's Eli Lilly position peaked at $312M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.